The CDC released its Morbidity and Mortality Weekly Report (MMWR) with the official policy statement regarding the two-dose HPV vaccine schedule. Here is a direct link to the HPV information: https://www.cdc.gov/mmwr/volum
Vaccination against human papillomavirus (HPV) is recommended to prevent HPV infections and HPV-associated diseases, including cancers. Routine vaccination at age 11 or 12 years has been recommended by the Advisory Committee on Immunization Practices (ACIP) since 2006 for females and since 2011 for males (1,2). This report provides recommendations and guidance regarding use of HPV vaccines and updates ACIP HPV vaccination recommendations previously published in 2014 and 2015 (1,2). This report includes new recommendations for use of a 2-dose schedule for girls and boys who initiate the vaccination series at ages 9 through 14 years. Three doses remain recommended for persons who initiate the vaccination series at ages 15 through 26 years and for immunocompromised persons.
Selected AHEC entities in all 50 states will work to increase awareness as well as train health professionals about the HPV vaccine. Each State entity will tailor their approach to clinician training based on needs in their states. Activities planned to date include:
• Grand Rounds presentations
• Webinars and Online learning modules
• Educational presentations at local, regional and state health profession conferences Texas Nurses Association, Indiana Association of Physician Assistants)
• Dissemination of CDC “You are the Key” materials to AHEC preceptors, educating health professional students in rural and underserved communities.
Additional Links to Information